Literature DB >> 22283678

Common and less common peripheral nerve disorders associated with diabetes.

Michael Knopp1, Yusuf A Rajabally.   

Abstract

Diabetes can be associated with a number of peripheral nerve disorders. The commonest is slowly-progressive axonal distal symmetrical sensori-motor neuropathy. Sensory loss and positive sensory symptoms are its main manifestations. Lumbosacral radiculoplexus neuropathy (LSRPN) is a distinct entity, accompanied by severe lumbar, hip, leg pain and weight loss, with subsequent weakness. Although typically unilateral, bilaterality is described, with spontaneous recovery usual over several months. The upper limb counterpart, cervical radiculoplexus neuropathy is rare. Acute painful neuropathies, including "diabetic neuropathic cachexia", are infrequent. Accompanying weight loss is usual and burning pains in the extremities are severe. Insulin-triggered acute painful neuropathy is well-described although infrequent and still poorly-understood. Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) represents an immune-mediated treatable disorder, usually causing prominent diffuse motor weakness, which was described as more common in diabetics. More recent epidemiological data have however been conflicting and it is possible that CIDP is no more frequent in diabetics than in the general population. Diagnosis is made by electrophysiology and cerebrospinal fluid analysis. A painless diabetic motor neuropathy, thought to be caused by ischaemic injury and microvasculitis, has recently been postulated as separate from LSRPN and CIDP. Other focal and multifocal neuropathies that can occur in diabetics are cranial or truncal. Entrapment neuropathies are more often of median and ulnar nerves, and may in some cases benefit from decompression. Finally, autonomic neuropathies are well-described in diabetes and can be diverse in presentation with cardiovascular, gastrointestinal, urogenital and sudomotor manifestations. Their management can be difficult with debilitating symptoms despite treatment.

Entities:  

Mesh:

Year:  2012        PMID: 22283678     DOI: 10.2174/157339912800564034

Source DB:  PubMed          Journal:  Curr Diabetes Rev        ISSN: 1573-3998


  7 in total

Review 1.  Chronic Inflammatory Demyelinating Polyradiculoneuropathy in Association With Concomitant Diseases: Identification and Management.

Authors:  Yan Chen; Xiangqi Tang
Journal:  Front Immunol       Date:  2022-07-04       Impact factor: 8.786

2.  Diabetic Neuropathic Cachexia: A Clinical Case and Review of Literature.

Authors:  Alessio Bellelli; Daniele Santi; Manuela Simoni; Carla Greco
Journal:  Life (Basel)       Date:  2022-05-04

Review 3.  Entrapment neuropathies in diabetes mellitus.

Authors:  Eugenia Rota; Nicola Morelli
Journal:  World J Diabetes       Date:  2016-09-15

Review 4.  Phenotyping animal models of diabetic neuropathy: a consensus statement of the diabetic neuropathy study group of the EASD (Neurodiab).

Authors:  G J Biessels; V Bril; N A Calcutt; N E Cameron; M A Cotter; R Dobrowsky; E L Feldman; P Fernyhough; J Jakobsen; R A Malik; A P Mizisin; P J Oates; I G Obrosova; R Pop-Busui; J W Russell; A A Sima; M J Stevens; R E Schmidt; S Tesfaye; A Veves; A I Vinik; D E Wright; S Yagihashi; M A Yorek; D Ziegler; D W Zochodne
Journal:  J Peripher Nerv Syst       Date:  2014-06       Impact factor: 3.494

Review 5.  Brain changes in diabetes mellitus patients with gastrointestinal symptoms.

Authors:  Anne M Drewes; Eirik Søfteland; Georg Dimcevski; Adam D Farmer; Christina Brock; Jens B Frøkjær; Klaus Krogh; Asbjørn M Drewes
Journal:  World J Diabetes       Date:  2016-01-25

6.  Concomitance of diabetic neuropathic amyotrophy and cachexia: a case report with review of the literature.

Authors:  Tuba Tulay Koca
Journal:  North Clin Istanb       Date:  2015-09-25

Review 7.  Diabetic foot and exercise therapy: step by step the role of rigid posture and biomechanics treatment.

Authors:  Piergiorgio Francia; Massimo Gulisano; Roberto Anichini; Giuseppe Seghieri
Journal:  Curr Diabetes Rev       Date:  2014-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.